Emergent BioSolutions to Participate in First Quarter 2017 Investor Conferences
December 29 2016 - 4:15PM
Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member
of the company’s senior management team will participate in the
following investor conferences during the first quarter of 2017.
- 35th Annual J.P. Morgan Healthcare Conference
San Francisco, CAJanuary 9-12, 2017Presentation: January 10,
2017
- Wells Fargo Specialty and Generic Drug
SummitOrlando, FLFebruary 13, 2017Presentation time
TBD
- Cowen & Co. 37th Annual Health Care
ConferenceBoston, MAMarch 6-8, 2017Presentation day and
time TBD
Presentation dates and times will be updated on the Emergent
website www.emergentbiosolutions.com under “Investors” as this
information becomes available.
For these conferences, the company will be webcasting its
presentation, which may include a discussion of the company's
recent business developments as well as its most recently reported
financial results and guidance. The webcasts will be available both
live and by replay, accessible from the Emergent website.
About Emergent BioSolutionsEmergent
BioSolutions is a global specialty biopharmaceutical company
dedicated to one simple mission—to protect and enhance life. We
develop, manufacture, and deliver a portfolio of medical
countermeasures for biological and chemical threats as well as
emerging infectious diseases. Through our work, we envision
protecting and enhancing 50 million lives with our products by
2025. Additional information about the company may be found at
www.emergentbiosolutions.com. Follow us @emergentbiosolu.
Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
BurrowsR@ebsi.com
Media Contact:
Tracey Schmitt Lintott
Senior Vice President, Global Public Affairs
240-631-3394
SchmittT@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024